Microvascular Therapeutics Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100. | ![]() CIRS CIRS (also known as Computerized Imaging Reference Systems) is a company that manufactures tissue equivalent phantoms and simulators intended to improve upon existing tissue simulation methodology. | ![]() Viewpoint Molecular Targeting Viewpoint Molecular Targeting is a radiopharmaceutical company that develops alpha-particle therapy for cancer. | |||
Founding Date | Founding Date 2014 | Founding Date 2016 | Founding Date 2011 | Founding Date 1982 | Founding Date 2008 |
Type | Type Subsidiary | Type Private | Type Private | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations Oxford, GB HQ Dublin, IE Burlington, US | Locations Tucson, US HQ | Locations Montpellier, FR HQ Grabels, FR | Locations Norfolk, US HQ | Locations Coralville, US HQ |
Employees | Employees 1061% decrease | Employees 1220% increase | Employees 614% decrease | Employees 254% decrease | Employees 517% decrease |
Funding | |||||
Total funding raised | Total funding raised $ 19.7m | Total funding raised $ 1.6m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 300k |
Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100.
View company
SurgiMab is a company that develops of intraoperative detection of tumors.
View company
CIRS (also known as Computerized Imaging Reference Systems) is a company that manufactures tissue equivalent phantoms and simulators intended to improve upon existing tissue simulation methodology.
View company
Viewpoint Molecular Targeting is a radiopharmaceutical company that develops alpha-particle therapy for cancer.
View company